Catalyst Pharmaceuticals Inc (CPRX)
15.34
-0.65
(-4.07%)
USD |
NASDAQ |
Apr 18, 16:00
15.34
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Free Cash Flow (Quarterly): 53.33M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.33M |
| September 30, 2023 | -34.22M |
| June 30, 2023 | 30.75M |
| March 31, 2023 | 12.00M |
| December 31, 2022 | 40.08M |
| September 30, 2022 | 41.30M |
| June 30, 2022 | 26.16M |
| March 31, 2022 | 8.478M |
| December 31, 2021 | 19.14M |
| September 30, 2021 | 21.64M |
| June 30, 2021 | 15.67M |
| March 31, 2021 | 2.903M |
| December 31, 2020 | 13.10M |
| September 30, 2020 | 11.44M |
| June 30, 2020 | 13.26M |
| March 31, 2020 | 7.213M |
| December 31, 2019 | 12.29M |
| September 30, 2019 | 16.26M |
| June 30, 2019 | 14.06M |
| March 31, 2019 | -8.022M |
| December 31, 2018 | -8.408M |
| September 30, 2018 | -6.976M |
| June 30, 2018 | -4.774M |
| March 31, 2018 | -6.081M |
| December 31, 2017 | -4.030M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.633M |
| June 30, 2017 | -3.201M |
| March 31, 2017 | -3.879M |
| December 31, 2016 | -4.419M |
| September 30, 2016 | -3.278M |
| June 30, 2016 | -4.432M |
| March 31, 2016 | -5.930M |
| December 31, 2015 | -4.631M |
| September 30, 2015 | -5.358M |
| June 30, 2015 | -4.247M |
| March 31, 2015 | -3.803M |
| December 31, 2014 | -3.994M |
| September 30, 2014 | -3.566M |
| June 30, 2014 | -2.997M |
| March 31, 2014 | -2.442M |
| December 31, 2013 | -4.130M |
| September 30, 2013 | -1.684M |
| June 30, 2013 | -1.812M |
| March 31, 2013 | -2.259M |
| December 31, 2012 | -1.639M |
| September 30, 2012 | -1.101M |
| June 30, 2012 | -1.146M |
| March 31, 2012 | -1.306M |
| December 31, 2011 | -1.44M |
| September 30, 2011 | -1.253M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-34.22M
Minimum
Sep 2023
53.33M
Maximum
Dec 2023
17.10M
Average
14.06M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| Pfizer Inc | 4.196B |
| Sarepta Therapeutics Inc | -73.70M |
| PTC Therapeutics Inc | -128.75M |
| Corcept Therapeutics Inc | 5.887M |
| Cytokinetics Inc | -74.11M |